Navigation Links
Basil Zimmo Joins Finesse Solutions as Vice-President of Software
Date:5/6/2008

SANTA CLARA, Calif., May 6 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of international program and senior management experience, with a focus on implementing high efficiency engineering, resource optimization, and global performance metrics. Basil was most recently a Senior Program Manager for handheld products at Research in Motion (RIM). Prior to joining RIM, Basil held senior management roles at Picarro Canada, Inc. and telecommunications companies such as Nortel Networks and JDS Uniphase, and has held positions at semiconductor chip companies such as AMD, Mitel Semiconductor, Phillips Semiconductor, GEC Plessey and Hughes Aircraft Company.

At Finesse Solutions, Mr. Zimmo will lead the new, Santa Clara-based software team in developing the TruBio bioreactor control platform. Mr. Zimmo said, "I am delighted to join Finesse, and work closely with both sensor and hardware teams to develop the next generation TruBio software. Finesse has a unique opportunity to innovate and address the evolving needs of bio-processing applications."

According to Finesse Solutions CEO Dr. Barbara Paldus, "We are delighted to embark on developing future versions of TruBio software based on state-of-the art programming platforms, that will future-proof our offering and add new capabilities for end users. We look forward to offering end users significantly improved code and novel, advanced features in the near future."

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
3. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
4. Harvey Morgan Joins CryoLife Board of Directors
5. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
6. Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner
7. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
8. Dr. Elizabeth Brown Joins Argenta TEC
9. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
10. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
11. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):